MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,000 | -32.1% | 6,857 | -7.8% | 0.00% | – |
| Q2 2023 | $81,000 | +2600.0% | 7,439 | +1531.4% | 0.00% | – |
| Q1 2023 | $3,000 | – | 456 | +714.3% | 0.00% | – |
| Q4 2022 | $0 | – | 56 | +7.7% | 0.00% | – |
| Q3 2022 | $0 | – | 52 | +10.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 47 | -98.0% | 0.00% | – |
| Q1 2022 | $21,000 | -77.7% | 2,316 | -70.7% | 0.00% | – |
| Q4 2021 | $94,000 | +147.4% | 7,900 | +138.9% | 0.00% | – |
| Q3 2021 | $38,000 | -17.4% | 3,307 | +27.6% | 0.00% | – |
| Q2 2021 | $46,000 | +21.1% | 2,591 | +6.3% | 0.00% | – |
| Q1 2021 | $38,000 | +850.0% | 2,438 | +694.1% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 307 | +293.6% | 0.00% | – |
| Q3 2020 | $1,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $33,936,000 | 7.88% |
| VR Adviser, LLC | 3,156,803 | $29,516,000 | 4.78% |
| Bleichroeder LP | 1,322,463 | $12,365,000 | 2.19% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $13,380,000 | 1.30% |
| 683 Capital Management, LLC | 1,932,829 | $18,072,000 | 0.97% |
| Granite Point Capital Management, L.P. | 472,056 | $4,414,000 | 0.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,766,000 | $25,862,000 | 0.79% |
| Avoro Capital Advisors LLC | 3,150,000 | $29,453,000 | 0.54% |
| Artal Group S.A. | 1,000,000 | $9,350,000 | 0.39% |
| Stonepine Capital Management, LLC | 56,747 | $531,000 | 0.22% |